Mark Hahn

Mark Hahn

Director of Finance/CFO bij VERONA PHARMA PLC

Vermogen: 138 M $ op 29-02-2024

61 jaar
Communications
Health Technology
Consumer Durables

Profiel

Currently, Mark W.
Hahn
is Chief Financial Officer of Verona Pharma Plc.
He is also on the board of ALSP Orchid Acquisition Corp.
I.
In his past career Mr. Hahn was Chief Financial Officer of Charles & Colvard Ltd., Chief Financial Officer for Equitel, Inc., Chief Financial Officer & VP-Administration at Gigabeam Corp., Chief Financial Officer for BuildLinks, Inc., Chief Financial Officer at Athenix Corp., Chief Financial Officer & Executive Vice President for Cempra Pharmaceuticals, Inc., Chief Financial Officer & Executive Vice President for Cempra, Inc., Chief Financial Officer at Performaworks, Inc., Chief Financial Officer of Dova Pharmaceuticals, Inc. and Principal at Ernst & Young LLP.
He received an undergraduate degree from the University of Wisconsin-Milwaukee.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
01-02-2024 64 268 512 ( 13.38% ) 138 M $ 29-02-2024

Actieve functies van Mark Hahn

BedrijvenFunctieBegin
VERONA PHARMA PLC Director of Finance/CFO 01-03-2020
ALSP ORCHID ACQUISITION CORPORATION I Director/Board Member 01-11-2021
Alle actieve functies van Mark Hahn

Eerdere bekende functies van Mark Hahn

BedrijvenFunctieEinde
DOVA PHARMACEUTICALS, INC. Director of Finance/CFO 12-11-2019
Director of Finance/CFO 01-11-2017
Director of Finance/CFO 01-01-2009
GIGABEAM CORPORATION Director of Finance/CFO 31-08-2008
Ervaring van Mark Hahn in detail bekijken

Opleiding van Mark Hahn

University of Wisconsin-Milwaukee Undergraduate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Mark Hahn in detail bekijken

Connecties

88

Eerstegraads connecties

11

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven2
CHARLES & COLVARD, LTD.

Consumer Durables

VERONA PHARMA PLC

Health Technology

Bedrijven in privébezit8

Communications

Commercial Services

Technology Services

Communications

Process Industries

Health Technology

Dova Pharmaceuticals, Inc.

Finance

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Mark Hahn